![](https://endpts.com/wp-content/uploads/2022/09/peer_review_tile.jpg)
Fourth time's the charm? bluebird picks up new finance chief; New CEOs here and there
→ bluebird bio has been able to cinch two FDA OKs, one for Zynteglo and the other for Skysona, in quick succession, but has had …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.